[Caffeine in Parkinson's disease].
Ferré
Sergi
S
Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services. Baltimore. Maryland, USA. sferre@intra.nida.nih.gov
D002110:Caffeine / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000517:prevention & control*
D000697:Central Nervous System Stimulants; D002110:Caffeine